AU2016260473A1 - cMLCK gene introduction - Google Patents

cMLCK gene introduction Download PDF

Info

Publication number
AU2016260473A1
AU2016260473A1 AU2016260473A AU2016260473A AU2016260473A1 AU 2016260473 A1 AU2016260473 A1 AU 2016260473A1 AU 2016260473 A AU2016260473 A AU 2016260473A AU 2016260473 A AU2016260473 A AU 2016260473A AU 2016260473 A1 AU2016260473 A1 AU 2016260473A1
Authority
AU
Australia
Prior art keywords
cmlck
subject
seq
vector
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016260473A
Other languages
English (en)
Inventor
Mingdong Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zensun Shanghai Science and Technology Ltd
Original Assignee
Zensun Shanghai Science and Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zensun Shanghai Science and Technology Ltd filed Critical Zensun Shanghai Science and Technology Ltd
Publication of AU2016260473A1 publication Critical patent/AU2016260473A1/en
Assigned to ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD. reassignment ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD. Amend patent request/document other than specification (104) Assignors: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY CO., LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11018—Myosin-light-chain kinase (2.7.11.18)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2016260473A 2015-05-08 2016-06-14 cMLCK gene introduction Abandoned AU2016260473A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510232415.6A CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
CNCN201510232415.6 2015-05-08
PCT/CN2016/085699 WO2016180377A1 (zh) 2015-05-08 2016-06-14 cMLCK基因导入

Publications (1)

Publication Number Publication Date
AU2016260473A1 true AU2016260473A1 (en) 2017-12-21

Family

ID=57247711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016260473A Abandoned AU2016260473A1 (en) 2015-05-08 2016-06-14 cMLCK gene introduction

Country Status (10)

Country Link
US (1) US20180133291A1 (enExample)
EP (1) EP3295959A4 (enExample)
JP (1) JP2018515510A (enExample)
KR (1) KR20190008511A (enExample)
CN (3) CN111388682A (enExample)
AU (1) AU2016260473A1 (enExample)
BR (1) BR112017024065A2 (enExample)
CA (1) CA2985396A1 (enExample)
RU (1) RU2017142779A (enExample)
WO (1) WO2016180377A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
RU2650635C2 (ru) 2012-10-08 2018-04-16 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入
CN115838437A (zh) * 2022-11-04 2023-03-24 广州达安基因股份有限公司 人NT-proBNP融合蛋白及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375185B2 (en) * 2000-09-12 2008-05-20 The United States Of America As Represented By The Department Of Health And Human Services Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
JP2009242388A (ja) * 2008-03-14 2009-10-22 National Cardiovascular Center 心臓特異的キナーゼの心不全診断および治療への応用
CN102416184A (zh) * 2011-12-08 2012-04-18 哈尔滨医科大学 microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入

Also Published As

Publication number Publication date
CN106177992A (zh) 2016-12-07
CA2985396A1 (en) 2016-11-17
RU2017142779A (ru) 2019-06-10
EP3295959A4 (en) 2019-01-02
US20180133291A1 (en) 2018-05-17
EP3295959A1 (en) 2018-03-21
CN107735109A (zh) 2018-02-23
KR20190008511A (ko) 2019-01-24
RU2017142779A3 (enExample) 2019-12-03
CN111388682A (zh) 2020-07-10
JP2018515510A (ja) 2018-06-14
BR112017024065A2 (pt) 2018-08-07
WO2016180377A1 (zh) 2016-11-17

Similar Documents

Publication Publication Date Title
AU2007221470B2 (en) Phosphatase inhibitor Protein-1 as a regulator of cardiac function
AU2004204815B2 (en) Method for in vivo regulation of cardiac muscle contractility
US20180243378A1 (en) Treating cardiovascular or renal diseases
US20180133291A1 (en) Cmlck gene transfer
US20180099029A9 (en) Serca2 therapeutic compositions and methods of use
WO2017029206A1 (en) Use of k2p potassium channel for altering the electrophysiology of the heart
US20250057982A1 (en) Proteins with cardioprotective activity
TW202400798A (zh) 斑菲素蛋白—２（ｐｌａｋｏｐｈｉｌｌｉｎ—２）基因療法之治療方法
KR20230035584A (ko) Dwarf 개방 판독 프레임을 위한 아데노-관련 바이러스 벡터
US20230183320A1 (en) Recombinant fibcd1 and use therof in the treatment of muscle atrophy
WO2002046220A2 (en) Sequences upstream of the carp gene, vectors containing them and uses thereof
AU2002226400A1 (en) Sequences upstream of the carp gene, vectors containing them and uses thereof
US10835620B2 (en) Methods for treating heart failure using beta-ARKnt peptide
US20230250450A1 (en) NRF2 Activator for Use in Treating Dilated Cardiomyopathies
WO2025235622A1 (en) Combinatorial gene therapy approaches
WO2015153357A1 (en) Compositions and methods for improving cardiac function
CN119233831A (zh) 用于与肌营养不良蛋白有关的心肌病的基因疗法组合物和治疗
Bish Myostatin regulation and function in the heart
HK1129392A (en) Phosphatase inhibitor protein-1 as a regulator of cardiac function
HK1083065B (en) Method for in vivo regulation of cardiac muscle contractility

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.

Free format text: FORMER NAME(S): ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY CO., LTD.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application